Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents
R Dinarvand1,2, N Sepehri1, S Manoochehri1, H Rouhani1, F Atyabi1,21Department of Pharmaceutics, Faculty of Pharmacy, 2Nanotechnology Research Centre, Tehran University of Medical Sciences, Tehran, IranAbstract: The effectiveness of anticancer agents may be hindered by low solubility in water, poor...
Guardado en:
Autores principales: | Rouhani H, Manoochehri S, Sepehri N, R, Atyabi F, Dinarv |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/186619282f5c4b89b205f8edba484838 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Preparation of polylactide-co-glycolide nanoparticles incorporating celecoxib and their antitumor activity against brain tumor cells
por: Jung S., et al.
Publicado: (2011) -
Structural and functional characterization of proteins adsorbed on hydrophilized polylactide-co-glycolide microfibers
por: Vasita R, et al.
Publicado: (2011) -
Chitosan–Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study
por: Ostad SN, et al.
Publicado: (2012) -
pH-sensitive poly(lactide-co-glycolide) nanoparticle composite microcapsules for oral delivery of insulin
por: Sun S, et al.
Publicado: (2015) -
Codelivery of doxorubicin and elacridar to target both liver cancer cells and stem cells by polylactide-co-glycolide/d-alpha-tocopherol polyethylene glycol 1000 succinate nanoparticles
por: Chen D, et al.
Publicado: (2018)